Wednesday, January 10, 2024 10:13:29 AM
For many (at least on this board), AVXL is seen as a get rich quick equity. Tremendous game-changing science, that will transform the treatment and prevent any number of CNS (central nervous system) diseases, and others.
But, as everyone has seen, commercialization of any of the Anavex molecules has been painfully slow and indeterminate. Personally, five or six years ago I thought that 2023 would be Anavex's come-out year. I was wrong.
When will it be? I'm no longer making predictions, either to myself or to message board readers. I still believe, based on the company's transforming and proprietary sigma-1 receptor activation science, Anavex Life Sciences Corp is destined to be a major global pharmaceutical. But that certainly didn't happen in 2023, and won't happen in 2024. But sooner or later (Ok, later), Anavex will gain approval somewhere in the world to sell at least one of its drugs; in time, probably several. When the amorphous, conceptual "market" sees that, the AVXL share price will ascend, never to retreat.
There are millions of AVXL shares held in short positions; in the belief that Anavex will fail, and its share price will plummet; yielding big gains for the owners of short positions. A few others have accumulated gigantic AVXL positions, of tens to hundreds of thousands of shares, anticipating great wealth when Anavex can sell a drug. But most who monitor the postings on this board have small or moderate AVXL positions, or none at all --- merely being entertained by the diversity and novelty of the messages (such as this one).
So, what's to actually happen? That's for each reader to decide for himself. So far, the shorts haven't relented. In fact, nothing, price-wise, has changed much at all. AVXL didn't get to $50 or $60, nor did it slide to $4. Over the years, at a nice low average cost basis, I've accumulated a modest AVXL position; one that I intend to hold until the share price drops to my average cost basis level. Should that happen, I'll liquidate and owe no capital gains taxes. My few thousand dollars in my position will not have produced a penny. But I understood this possibility from the start --- used only small amounts of discretionary dollars to buy my AVXLs. If Anavex fails (I don't think it will) my life will be unaffected. If it succeeds (as I believe it eventually will do), my beneficiaries, my wife and children, will benefit wonderfully. I'm not a stock trader. Buy; hold. In a few years, I'm hoping to receive dividends from Anavex Life Sciences Corp.
But with the apparent failure of blarcamesine for Rett, how could Anavex succeed? I await the publication of the peer-reviewed article in a major science journal, which will bring respected light to the topic. And, of course, blarcamesine may actually gain approval for Rett. Blarcamesine may gain approval for Parkinson's disease dementia and Alzheimer's. Then, Anavex 3-71 is likely to be Anavex's major drug, supplanting blarcamesine, for an even wider number of diseases and conditions. Eventual generalized use of an Anavex sigma-1 receptor agonist as a general disease and aging prophylactic, in perhaps ten years, will be transforming.
Or, none of those projections ever occur, and Anavex Life Sciences Corp dissolves. Each reader will have to decide, and act accordingly. Personally, I still hold to Anavex's eventual success. I'll be standing on the sidelines of this on-going big game and watch. The game clock turns much more slowly than I presumed -- but it still operates. Anavex science is still unique and valid. It's just gonna take longer to be applied and be available. I can wait.
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM